Dragonfly Energy Holdings Corp. — Form 8-K Summary
Reporting/event date: September 30, 2026. This current report describes amendments and waivers involving the company’s senior secured term loan and Series B Convertible Preferred Stock. It does not report quarterly operating results.
Key financial and contractual terms
- Term loan and liquidity: Lenders waived testing of the minimum liquidity covenant solely for the fiscal month ended September 30, 2026. The filing provides no liquidity balance or other financial results.
- Debt amendment fee: The company owes a $450,000 fee, payable in kind by adding it to the outstanding term-loan principal.
- Series B dividends: Holders waived the right to receive the full cash dividend for the quarter ended September 30 by October 1. The company must pay cash dividends at a 2% annual rate by October 1 and at a 6% annual rate by October 30. Payment-in-kind dividends continue accruing at 2% annually.
- Default treatment: If the company follows the revised dividend schedule, the deferral will not constitute a Non-Payment Event or Preferred Default. Lenders also waived a term-loan default arising from the deferral, subject to compliance with that schedule.
Changes, outlook, and risks
The filing reports no revenue, profit, cash flow, margin, debt-balance, or guidance figures, and provides no management outlook. The limited liquidity-covenant waiver and the rescheduling of a preferred-stock cash dividend are material financing developments. The $450,000 fee increases term-loan principal; the filing does not state the resulting principal balance. The waivers are limited in scope and do not establish that future covenant tests or payments have been waived.
Important facts for investors to verify
- Whether the company paid the required Series B cash dividends by October 1 and October 30, 2026.
- The company’s liquidity position and the status of subsequent minimum-liquidity covenant tests.
- The updated term-loan principal balance, including the capitalized $450,000 fee, and any further amendments or waivers.
- The full terms of the Eighth Amendment and Series B Waiver, filed as Exhibits 10.1 and 10.2.